-
Staying Safe: The Importance of Medication Monitoring as the Pandemic Continues
Date and Time: Date: August 31, 2021 Time: 9 am or 1 pm Central Time
Length: 15 minutes
Please join us for a brief webinar discussing the importance of medication monitoring and strategies to overcome potential barriers to successful treatment during the ongoing pandemic.
Register
-
Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?
Date and Time: August 31, 2021
Length: 15 minutes
-
Toolkit for Buprenorphine Practices
Date and Time: July 29, 2021
Length: 30 minutes
-
Finding Fentanyl
Date and Time: June 24, 2021
Length: 15 minutes
-
NPS Focus: "Nitazene" Synthetic Opioids
Date and Time: July 22, 2021
Length: 15 minutes
-
Interpretation of Buprenorphine Results: Considerations for Dosage Form and Specimen Type
Date and Time: May 20, 2021
Length: 15 minutes
-
Trends in Novel Psychoactive Substances
Date and Time: April 29, 2021
Length: 30 minutes
-
NPS Focus: Designer Benzodiazepines
Date and Time: March 25, 2021
Length: 15 minutes
-
Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™
Date and Time: Feb 25, 2021
Length: 11 minutes
-
Increase in Drug Overdoses Due to Synthetic Opioids During the COVID-19 Pandemic
Date and Time: January 28, 2021
Length: 14 minutes
-
What Did My Patient Actually Take? An Overview of Dextromethorphan/Levorphanol Results
Date and Time: December 17, 2020
Length: 12 minutes
-
COVID-19 and Its Impact on Persons with Mental Illness and Substance Use
Date and Time: October 29, 2020
Length: 15 minutes
-
Drug-Drug Interactions (DDI) amidst the Pandemic and Opportunities for Objective DDI Monitoring via Oral Fluid Testing
Date and Time: December 3, 2020
Length: 16 minutes
-
Emerging Data on Novel Psychoactive Substances and Clinical Effects
Date and Time: September 23, 2020
Length: 15 minutes
-
Novel Psychoactive Substance Testing
Date and Time: September 13, 2020
Length: 37 minutes
-
Designer Opioids and Benzodiazepines
Date and Time: August 27, 2020
Length: 19 minutes
-
Synthetic Cannabinoids and Synthetic Stimulants
Date and Time: July 23, 2020
Length: 9 minutes
-
Expansion of Oral Fluid Testing of Behavioral Health Drugs
Date and Time: June 23, 2020
Length: 13 minutes
-
Review of New InterAct Rx Analyte Positivity
Date and Time: May 28, 2020
Length: 9 minutes
-
An Overview of Oral Fluid Testing
Date and Time: May 13, 2020
Length: 13 minutes
-
Downstream effects of COVID-19 on your patients
Date and Time: April 21, 2020
Length: 30 minutes
-
Kratom: New Year, New Insights
Date and Time: February 4, 2020
Length: 10 minutes
-
Introduction to PGx for Pain Management
Date and Time: March 26, 2020
Length: 15 minutes
-
What Did My Patient Actually Take? A Review of Opioid Results Interpretation
Date and Time: November 21, 2019
Length: 12 minutes
-
What Did My Patient Actually Take? An Overview of Benzodiazepine Results
Date and Time: December 17, 2019
Length: 12 minutes
-
What Did My Patient Actually Take? Unexpected Causes of Cocaine Results
Date and Time: August 29, 2019
Length: 15 minutes
-
What Did My Patient Actually Take? An Overview of Methamphetamine Results
Date and Time: July 17, 2019
Length: 13 minutes
-
What Did My Patient Actually Take? An Overview of Amphetamine Results
Date and Time: June 27, 2019
Length: 13 minutes
-
What Did My Patient Actually Take? An Overview of Marijuana Results
Date and Time: October 24, 2019
Length: 8 minutes
-
Enhanced DDI Identification and Patient Care with InterACT Rx
Date and Time: March 15, 2019
Length: 27 minutes
-
Medication Monitoring Program Essentials
Date and Time: February 26th, 2019
Length: 31 minutes